tag ai-drug-discovery 
Intouch Solutions
APRIL 11, 2024
It has continually evolved, embracing new technologies and methodologies to improve drug discovery, development, and distribution. Pre-Clinical : Deeper comprehension of the impacts and outcomes associated with a particular drug. What needs to be done before implementing AI in precision engagement?
Drug Discovery World
AUGUST 15, 2022
Samantha Kanza, Senior Enterprise Fellow, University of Southampton, will be speaking at the Tech Theatre, ELRIG Drug Discovery 2022, sponsored by DDW. . The Tech Theatre will feature a series of seminars focused on automation and technology for drug discovery. . The sustainable lab. The automated lab and the human.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
OCTOBER 3, 2022
A series of short seminars focused on automation and technology will be available to visitors at Drug Discovery 2022 which takes place at the ExCel, London 4 and 5 October. will discuss The role of AI and Automation in Personalised Medicine: How can AI Help in the Post- Drug Discovery Process.
pharmaphorum
NOVEMBER 28, 2022
Substra is the software that powered the MELLODDY platform, a collaboration in which Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Janssen, Merck, Novartis, and Servier all agreed to share drug discovery data — but not with each other directly, nor with Owkin.
Drug Discovery World
NOVEMBER 9, 2023
Novel platforms This session will begin with chariperson’s remarks from Lars Linden, PhD, Vice President, Head, Biologics Research, Bayer HealthCare, which will be followed by a keynote presentation by Agnieszka Kielczewska, PhD, Director, Research, Antibody Discovery and Screening, Biologics Discovery, Amgen.
Drug Discovery World
FEBRUARY 9, 2023
Andrew A Radin Chief Executive Officer of Aria Pharmaceuticals, on the critical use of artificial intelligence in solving some of drug discovery’s most new and complex challenges. It also carries a much higher price tag for failure. I’ll preface this by saying the reasons to shy away from the latest technology are justified.
Drug Discovery World
NOVEMBER 13, 2023
Thereafter, the following presentations will take place: Melody Shahsavarian, PhD, Digital Biologics Platform, Large Molecules Research, Sanofi, on: ‘Enhancing antibody discovery with generative AI’. The panel discussion will be hosted by chairperson Erasmus and Greiff on the current state of AI in antibody therapeutics.
Expert insights. Personalized for you.
52 
Let's personalize your content